Tyme Technologies Inc. (TYME)

[murocman]

Thanks Mcsharkey. My frustration was not meant to be directed at you but more so at the company.

They have some promising molecules and technology in a tough space but the progress seems to be excruciatingly slow.

The fact that it took a formal ‘strategic review’ to figure out the best bang for the buck is to focus on 2nd rather than 3rd line Pancan treatment does not inspire confidence as to the company’s market savvy. Hopefully the science and data continue to be compelling.

Murocman